The largest database of trusted experimental protocols

Denp20

Manufactured by R&D Systems
Sourced in United States

DENP20 is a recombinant human protein produced in E. coli. It is a 20 kDa protein that functions as a dendritic cell nuclear protein.

Automatically generated - may contain errors

4 protocols using denp20

1

Quantification of CSF Protein Biomarkers

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following commercially available ELISAs were used to determine CSF protein levels of AGT, ENPP-2 and TRX-1: [AGT (JP27412; TECAN, IBL International GmbH, Europe), ENPP-2 (DENP20; R&D Systems, Europe), TRX-1 (RAB1756; Sigma-Aldrich, Merck KGaA, Germany)]. All ELISAs were performed according to the manufacturers’ protocols with samples diluted 1:200 for AGT, 1:40 for ENPP-2 and 1:2 for TRX-1. NG and NFL were determined by ELISA, as previously described.5 (link),26 (link) TRX-80 was quantified by an in-house ELISA, as previously published.10 (link),27 (link) Samples were tested in duplicate, and the average was considered for the statistical analyses. The calculated intra- and inter-assay coefficients of variation (CV%) were <6 and <15%, respectively, for the overall ELISAs. Samples with duplicate CV above 15% were remeasured or excluded from the analyses. Absorbance was measured with a microplate reader (Tecan Life Sciences, Männedorf, Switzerland). Concentrations were calculated by interpolation from the standard curves using GraphPad Prism 9 software, through a 4PL curve fit.
+ Open protocol
+ Expand
2

Quantification of CSF Protein Biomarkers

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following commercially available ELISAs were used to determine CSF protein levels of AGT, ENPP-2 and TRX-1: [AGT (JP27412; TECAN, IBL International GmbH, Europe), ENPP-2 (DENP20; R&D Systems, Europe), TRX-1 (RAB1756; Sigma-Aldrich, Merck KGaA, Germany)]. All ELISAs were performed according to the manufacturers’ protocols with samples diluted 1:200 for AGT, 1:40 for ENPP-2 and 1:2 for TRX-1. NG and NFL were determined by ELISA, as previously described.5 (link),26 (link) TRX-80 was quantified by an in-house ELISA, as previously published.10 (link),27 (link) Samples were tested in duplicate, and the average was considered for the statistical analyses. The calculated intra- and inter-assay coefficients of variation (CV%) were <6 and <15%, respectively, for the overall ELISAs. Samples with duplicate CV above 15% were remeasured or excluded from the analyses. Absorbance was measured with a microplate reader (Tecan Life Sciences, Männedorf, Switzerland). Concentrations were calculated by interpolation from the standard curves using GraphPad Prism 9 software, through a 4PL curve fit.
+ Open protocol
+ Expand
3

Plasma Biomarker Profiling in Research

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasma legumain concentrations were determined by enzyme immunoassay (EIA) with antibodies from R&D Systems (Duoset DY4769), Stillwater, MN. Serum levels of LDL-associated phospholipase A2 (Lp-PLA2) and autotaxin were determined by EIA from R&D systems (DPLG70 and DENP20, respectively). Plasma levels of tumor necrosis factor (TNF) was determined by a custom human cytokine kit, V-plex (cat # K151A0H-1), from Mesoscale Discovery, Rockville, MD. Plasma levels of platelet-factor (PF)4 (Cat# DY795), neutrophil-activating protein (NAP2/CXCL7) (Cat#DY393), regulated on activation, normal T cell expressed and secreted (RANTES/CCL5) (Cat#DY278) and soluble CD40 ligand (CD40L) (Cat#DY617) were measured by EIAs obtained from R&D Systems. The intra-and inter-assay coefficients of variations were <10% for all EIAs. Routine biochemical analysis was performed in clinical routine laboratory at Oslo University Hospital.
+ Open protocol
+ Expand
4

HBV Replication Inhibition by ENPP2 Targeting

Check if the same lab product or an alternative is used in the 5 most similar protocols
HBV replication-competent clone pSM2-HBV harboring a head-to-tail tandem dimer of the HBV genome (GenBank accession number: V01460) was provided by Dr. Hans Will (Heinrich-Pette-Institute, Germany). Small interfering RNAs (siRNAs) targeting ENPP2 were synthesized by Genepharma, Shanghai (sequences are listed in Supplementary Table S1). Secreted HBV surface antigen (HBsAg) and HBV e antigen (HBeAg) from cell culture media were detected by Roche Diagnostics (36461400, 33448500, respectively). Cultrex pathclear basement membrane extract (3432-010-01), an ELISA kit for detection of secreted ENPP2 (DENP20), and ENPP2 inhibitor PF-8380 (4078) were purchased from R&D system, United States. Cell counting kit-8 (CCK-8, 40203ES80) was purchased from Yeasen, China.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!